Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
CHESTERBROOK, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results